Get the Stockscreener App
139.91
5.55%
7.36
Pre-market:
141.25
1.34
+0.96%
Grail Inc stock is traded at $139.91, with a volume of 891.37K.
It is up +5.55% in the last 24 hours and up +10.26% over the past month.
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
See More
Previous Close:
$132.55
Open:
$134.83
24h Volume:
891.37K
Relative Volume:
1.18
Market Cap:
$6.25B
Revenue:
$156.12M
Net Income/Loss:
$-395.33M
P/E Ratio:
-13.48
EPS:
-10.3758
Net Cash Flow:
$-292.33M
1W Performance:
+12.22%
1M Performance:
+10.26%
6M Performance:
+154.29%
1Y Performance:
+64.60%
1-Day Range:
$0.00
$0.00
1-Week Range:
$123.20
$141.68
52-Week Range:
$41.50
$166.47
Grail Inc Stock (GRAL) Company Profile
Name
Grail Inc
Sector
Industry
Phone
(833) 694-2553
Address
1525 O'BRIEN DRIVE, MENLO PARK
Compare GRAL vs TMO, DHR, NTRA, A, IQV
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GRAL
Grail Inc
|
139.91 | 6.25B | 156.12M | -395.33M | -292.33M | -10.38 |
TMO
Thermo Fisher Scientific Inc
|
684.89 | 253.24B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
232.97 | 163.77B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
404.90 | 58.36B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
175.96 | 49.61B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
273.60 | 45.03B | 16.63B | 1.39B | 2.12B | 8.0674 |
Grail Inc Stock (GRAL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-17-26 | Initiated | RBC Capital Mkts | Sector Perform |
| Sep-09-26 | Resumed | UBS | Buy |
| Jun-05-26 | Initiated | Goldman | Neutral |
| Jun-02-26 | Resumed | Wolfe Research | Peer Perform |
| Apr-10-26 | Initiated | Mizuho | Neutral |
| Mar-18-26 | Upgrade | TD Cowen | Hold → Buy |
| Feb-19-26 | Initiated | TD Cowen | Hold |
| Feb-17-26 | Initiated | Robert W. Baird | Outperform |
| Dec-02-25 | Resumed | Morgan Stanley | Equal-Weight |
| Nov-12-25 | Upgrade | Guggenheim | Neutral → Buy |
| Apr-21-25 | Initiated | Canaccord Genuity | Buy |
| Nov-27-24 | Initiated | Morgan Stanley | Equal-Weight |
| Nov-15-24 | Initiated | Wolfe Research | Peer Perform |
| Oct-17-24 | Initiated | Guggenheim | Neutral |
View All
Grail Inc Stock (GRAL) Latest News
Grail CEO Joshua Ofman sells $2.74m in company stock - Investing.com
Form 4 Grail Inc: Joshua J. Ofman (Director, CEO) For: 15 October - Investing.com Nigeria
GRAIL Director Steven Mizell Acquires 148 Deferred Stock Units at $135.46 Each - Kalkine Media
GRAIL (GRAL) grants William J. Chase 153 stock units in lieu of $20.8K in director fees. - Stock Titan
GRAIL (GRAL) director Gregory L. Summe receives 237 stock units instead of $32.1K in cash fees. - Stock Titan
Under a prearranged trading plan, GRAIL (GRAL)'s CEO sold 20,000 shares. - Stock Titan
GRAIL (GRAL) grants director 148 stock units in lieu of $20.2K in cash fees - Stock Titan
A director proposes selling 5,000 GRAIL (GRAL) shares around October 15, 2026. - Stock Titan
Grail Stock Hit a 12-Month High After Its FDA Panel Win. But Here's the Risk Investors Shouldn't Ignore. - The Motley Fool
GRAIL's Chief Growth Officer Andrew Partridge Sells 7,873 Shares to Cover Tax Withholding - Kalkine Media
Grail CFO Aaron Freidin sells $3.46m in company stock - Investing.com
To cover vesting taxes, GRAIL (GRAL) CFO Aaron Freidin sells 23,619 shares. - Stock Titan
GRAIL Inc. Officer Andrew Partridge Files Form 144 to Sell 7,873 Shares for RSU Tax Withholding - Kalkine Media
An officer sold 7,873 shares to cover vesting taxes at GRAIL (NASDAQ: GRAL). - Stock Titan
After 45,840 shares vest, a GRAIL (GRAL) officer proposes selling stock to cover taxes. - Stock Titan
3 Reasons to Buy Grail (GRAL) Hand Over Fist in October - The Motley Fool
Form 4 Grail Inc For: 26 September By Investing.com - Investing.com UK
Grail CFO Aaron Freidin sells $382,679 in company stock By Investing.com - Investing.com South Africa
Grail CFO Aaron Freidin sells $382,679 in company stock - Investing.com
Grail CEO Joshua Ofman sells $6.0m in company stock on Sept. 21 - Investing.com
Form 4 Grail Inc For: 26 September By Investing.com - Investing.com Nigeria
GRAL DEADLINE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages GRAIL, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 4 Deadline in Securities Class ActionGRAL - TMX Newsfile
At prices up to $95 a share, GRAIL (GRAL) CFO Aaron Freidin sold 4,100 shares under a trading plan. - Stock Titan
Up to $5.8M in insider stock may be sold at GRAIL, Inc. (GRAL) - Stock Titan
GRAIL, Inc.Common Stock (Nasdaq:GRAL) Price Chart - The Chronicle-Journal
Analysts Offer Insights on NA Companies: Chime Financial, Inc. Class A (CHYM), GRAIL Inc (GRAL) and ServiceTitan, Inc. Class A (TTAN) - The Globe and Mail
UBS Initiates Coverage of Grail With Buy Rating, Caris, Tempus, Twist With Neutral - GenomeWeb
Grail CFO Sells 7,900 Shares Amid Strong Stock Performance - intellectia.ai
Grail CFO Aaron Freidin Sells 7,900 Shares for $672,000 - Yahoo Finance
GRAL INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
GRAL INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
Grail Stock Jumps in August as FDA Schedules a Key Meeting for its Galleri Cancer Test - Yahoo Finance
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PR Newswire
Have Insiders Sold GRAIL Shares Recently? - simplywall.st
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Moomoo
GRAIL (GRAL) Institutional Ownership 2026 $GRAL - MarketBeat
Grail CFO Aaron Freidin sells $671,579 in company stock By Investing.com - Investing.com South Africa
Grail CFO Aaron Freidin sells $671,579 in company stock - Investing.com
Grail CEO Joshua Ofman sells $425,098 in company stock - Investing.com
GRAIL CFO sells 7,900 shares at $85.01 avg | GRAL Insider Trading - Stock Titan
GRAIL to Present at Morgan Stanley's 24th Annual Global Healthcare Conference - TradingView
CEO of GRAIL (GRAL) sells 5,000 shares in preset trade - Stock Titan
GRAIL (NASDAQ: GRAL) insider Joshua Ofman plans to sell 10,000 shares - Stock Titan
GRAIL, Inc. (NASDAQ: GRAL) officer to sell 12,000 shares - Stock Titan
Biotech Frenzy Sends GRAIL Soaring Ahead of FDA Showdown - TipRanks
Investigation announced for Long-Term Investors in shares of GRAIL, Inc. (NASDAQ: GRAL) over potential Wrongdoing - openPR.com
GRAIL (GRAL) Earnings Report: Profit Per Share Surpasses Its Benchmark in the Current Update; Post-Report: The Market Price Advances 6.19% in Latest TradingGross Profit Margin - dars.gov.et
GRAIL (GRAL) Earnings Report: Profit Per Share Surpasses Its Benchmark in the Current Update; Post-Report: The Market Price Advances 6.19% in Latest TradingQuarterly Profit Report - Vinanet
Grail Stock Rockets Back As Traders Buy The Dip - TipRanks
GRAIL (GRAL), What Is Behind The Fresh Attention On The Stock? - simplywall.st
Grail Inc Stock (GRAL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Grail Inc Stock (GRAL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| JOSHUA OFMAN | Director |
Oct 15 '26 |
Proposed Sale |
139.70 |
5,000 |
698,500 |
0 |
| Freidin Aaron | Chief Financial Officer |
Oct 05 '26 |
Sale |
146.39 |
23,619 |
3,457,585 |
225,364 |
| Andrew Partridge | Officer |
Oct 05 '26 |
Proposed Sale |
146.39 |
7,873 |
1,152,533 |
0 |
| Aaron Freidin | Officer |
Oct 05 '26 |
Proposed Sale |
146.39 |
23,619 |
3,457,600 |
0 |
| Partridge Andrew John | Chief Growth Officer |
Oct 05 '26 |
Sale |
146.39 |
7,873 |
1,152,528 |
155,865 |
| Freidin Aaron | Chief Financial Officer |
Sep 21 '26 |
Sale |
93.34 |
4,100 |
382,679 |
248,983 |
| JOSHUA OFMAN | Director |
Sep 21 '26 |
Proposed Sale |
80.77 |
71,452 |
5,771,178 |
0 |
| Ofman Joshua J. | Chief Executive Officer |
Sep 21 '26 |
Sale |
97.74 |
61,452 |
6,006,378 |
362,271 |
| Ofman Joshua J. | Chief Executive Officer |
Sep 21 '26 |
Option Exercise |
14.00 |
26,452 |
370,328 |
423,723 |
| JOSHUA OFMAN | Director |
Aug 27 '26 |
Proposed Sale |
79.59 |
10,000 |
795,900 |
0 |
0.41%
3.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):